Development of a gmp manufacturing process for nadph oxidase correction in mRNA transfected granulocytes and monocytes for patients with chronic granulomatous disease

Category Primary study
JournalCytotherapy
Year 2020
This article has no abstract
Epistemonikos ID: 79a5c97a4b673c93b113ceffd7ce2471e76899f1
First added on: Feb 11, 2025